Teva Pharmaceutical Industries Ltd SEC filings TEVA

Teva Pharmaceutical Industries Ltd has 1,001 filings in SEC EDGAR's recent list, going back to Oct 17, 2017. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 31, 2026 Dec 31, 2025
10-K Annual report Feb 3, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 9, 2025 Dec 31, 2024
10-K Annual report Feb 5, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 16, 2024 Dec 31, 2023
10-K Annual report Feb 12, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 19, 2023 Dec 31, 2022
10-K Annual report Feb 10, 2023 Dec 31, 2022
10-K Annual report Feb 9, 2022 Dec 31, 2021
10-K Annual report Feb 10, 2021 Dec 31, 2020
10-K Annual report Feb 21, 2020 Dec 31, 2019
10-K Annual report Feb 19, 2019 Dec 31, 2018
10-K Annual report Feb 12, 2018 Dec 31, 2017

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TEVA (NYSE)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Tel Aviv
SEC filer status
Large accelerated filer
SEC CIK
818686
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.